Discovery, Innovation and Commercialization
Workshop Series &
Certificate Program
Discovery, Innovation and Commercialization
Workshop Series & Certificate Program
The Ohio State University Center for Clinical and Translational Science (CCTS),
in collaboration with Ohio State’s Fisher College of Business and College of Medicine,
is pleased to announce the “Discovery, Innovation and Commercialization Workshop
Series,” which will focus on commercializing innovations in health care and medicine.
Workshops will be held on Fridays, 1:00- 4:00 p.m., June 25, July 30, August 20, October 8
and October 29, 2010. Topic, agenda and location details for each workshop are below:
Workshop 1:
Discovery, Innovation and the Business of Medicine
Friday, June 25, 2010
1 - 4 p.m.
The Ohio State University Davis Heart and Lung Research Institute,
Room 170, 473 W. 12th Ave., Columbus
1:00 - 1:10
Welcome
Chandan Sen, PhD
Associate Dean for Research, Professor of Surgery, College of Medicine, Director of Pilot Studies Program-CCTS, and Executive Director of t the Comprehensive Wound Center, The Ohio State University.
Karen Wruck, PhD
Associate Dean for Graduate Programs, Dean’s Distinguished Professor and Professor of Finance,
Fisher College of Business, The Ohio State University
Rebecca Jackson, MD
Associate Dean for Clinical Research, Professor of Endocrinology, Diabetes, Metabolism,
Physical Medicine, College of Medicine, and Director of CCTS, The Ohio State University
1:10 - 1:30
Steven Gabbe, MD
Senior Vice President for Health Sciences, The Ohio State University, and
Chief Executive Officer, The Ohio State University Medical Center
1:30 - 1:50
Christine Poon
Dean and John W. Berry, Sr. Chair in Business, Fisher College of Business, The Ohio State University
The application for consultative services is available at
https://osu.qualtrics.com/SE/?SID=SV_4IvX1oHc9Hx8CHi.
1:50 - 2:05
Q&A for Steven Gabbe and Christine Poon
2:05 - 2:20
Break for refreshments
Otherwise, you may also visit www.cctsworkshops.eventbrite.com for a link to the
application and to register for and learn about workshops in this series.
2:20 - 2:40
Michael Bills
Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University
The goal of the five-workshop series is to provide CCTS pilot study awardees, K scholars
and other interested clinical and translational investigators with information and support
that will help them translate their scientific discoveries into commercially viable products
and services that improve patient outcomes.
CCTS pilot-funded investigators who attend at least four of the five workshops will receive
a certificate in “Discovery, Innovation, and New Product and Service Development”
and will be eligible to be selected for consultative support from the Fisher College of
Business to help commercialize their discoveries.
Follow us on Twitter, share your feedback, and help us spread the word about this
exciting workshop series! http://twitter.com/cctsworkshops
2:40 - 3:00 Jane New
Associate Director, Technology Licensing & Commercialization, The Ohio State University
3:00 - 3:10
Q&A for Michael Bills and Jane New
3:10 - 3:20
Setup and framing of breakout/discussion sessions
Michael Bills
3:20 - 3:40
Breakout sessions
3:40 - 3:50
Introduction of upcoming speakers
Chandan Sen, Karen Wruck, Michael Bills
3:50 - 4:00 Closing remarks
Chandan Sen, Karen Wruck
Workshop 2:
Commercialization and Incubation of Intellectual Property in Health Care and Medical Businesses
Friday, July 30, 2010
1 - 4 p.m.
The Ohio State University Biomedical Research Tower, Room 115, 460 W. 12th Ave., Columbus
1:00 - 1:10
Welcome
1:10 - 2:40
Presentations
Michael Camp, PhD
Academic Director, Center for Entrepreneurship, Fisher College of Business, The Ohio State University
Susan Rector
Partner, Intellectual Property and Technology Practice, Schottenstein Zox & Dunn, Columbus, Ohio
Earl LeVere
Partner, Intellectual Property and Technology Practice, Schottenstein Zox & Dunn, Columbus, Ohio
Orlando “Lon” Simonetti, PhD
Research Director, Cardiovascular MRI and CT, and Associate Professor of Internal Medicine and Radiology,
College of Medicine, The Ohio State University
2:40 - 2:55
Workshop 4
Allocating Research Resources: Evaluating, Attracting, and Researching Funding
Friday, October 8, 2010
1 - 4 p.m.
The Ohio State University Davis Heart and Lung Research Institute,
Room 170, 473 W. 12th Ave., Columbus
1:00 - 1:10
Welcome
Michael Bills
Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University
1:10 - 2:40
Presentations
Michael Leiblein, PhD
Associate Professor of Strategic Management, Fisher College of Business, The Ohio State University
Sampath Parthasarathy, PhD
Holder of the Klassen Chair in Cardiothoracic Surgery, Professor of Surgery, College of Medicine,
The Ohio State University; founder of InVasc Therapeutics
2:40 - 2:55
Q&A
Q&A
2:55 - 3:10
Break for refreshments
2:55 - 3:10 Break for refreshments
3:10 - 3:45
Breakout sessions
3:10 - 3:45 Breakout sessions
3:45 - 4:00 Closing remarks
Michael Bills
3:45 - 4:00 Closing remarks
Workshop 3
Innovation Practice and Process: A Patient & Caregiver-Centric Approach
Friday, August 20, 2010
1 - 4 p.m.
The Ohio State University Biomedical Research Tower, Room 115, 460 W. 12th Ave., Columbus
1:00 - 1:10
Welcome
Chip Souba, MD
Dean, College of Medicine, The Ohio State University
1:10 - 2:40
Presentations
Clay Marsh, MD
Senior Associate Vice President for Health Sciences Research; Vice Dean for Research and Professor of
Internal Medicine, College of Medicine; Executive Director of the Center for Personalized Health;
Director of the Center for Critical Care and Respiratory Medicine, The Ohio State University
Michael Bills
Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University
2:40 - 2:55
Q&A
2:55 - 3:10
Break for refreshments
3:10 - 3:45
Breakout sessions
3:45 - 4:00 Closing remarks
Workshop 5
The Crucial Role of Intangibles in the Health Care Innovation Value Chain
Friday, October 29, 2010
1 - 4 p.m.
The Ohio State University Davis Heart and Lung Research Institute,
Room 170, 473 W. 12th Ave., Columbus
1:00 - 1:10
Welcome
Michael Bills
Executive in Residence and Senior Lecturer, Fisher College of Business, The Ohio State University
1:10 - 2:40
Presentations
Anthony Rucci
Clinical Professor of Management and Associate to the Dean for Executive Education, Fisher College of Business,
The Ohio State University
Vincent Pompili, MD, FACC
Director of Interventional Cardiovascular Medicine, Director of Cell-Based Therapies, The Ohio State University Medical Center, Professor of Internal Medicine, College of Medicine, The Ohio State University
2:40 - 2:55
Q&A
2:55 - 3:10
Break for refreshments
3:10 - 3:45
Breakout sessions
3:45 - 4:00 Closing remarks
Michael Bills
The Speakers
Michael Bills
With more than two decades of experience in new product and brand
innovation, Michael Bills is an internationally recognized expert on consumer
centricity and the creation of integrated, multi-channel experiences for companies as diverse as GE, Calvin Klein, Microsoft, Coca-Cola and Apple. As Executive in Residence at The Ohio State University Fisher College of Business, Bills teaches graduate level courses in innovation and brand marketing and has developed
numerous platform elements for the Fisher Innovation Initiative. Prior to joining the Fisher College he
was Managing Partner, the Americas, for international consulting firm, Fitch (a division of WPP) and
was President of Retail Planning Associates. Bill’s work has taken him around the world, with
engagements in 17 countries; in addition, he has shared his perspectives on CNBC, CNN and Sky Radio,
as well as being quoted in leading publications including Time, BusinessWeek and Fortune Magazine.
S. Michael Camp, PhD
Dr. S. Michael Camp serves as the academic director for the Center for
Entrepreneurship in the Fisher College of Business at The Ohio State University. He is also founder and CEO of the Kairos IP Institute, a global expert network
and proprietary research organization for rapid screening and commercialization
of early-stage technology with emphasis on monetizing IP for the world’s leading R&D institutions. As academic director at Fisher, Dr. Camp sets the strategic
direction and programmatic platform for Ohio State’s entrepreneurship education program. He oversees
the design and development of the academic and outreach programs and directs strategic partnerships
with other entrepreneurship and technology commercialization support organizations.
Dr. Camp was recently recognized by CNN Money and Fortune Small Business as one of the top
entrepreneurship professors in the country. In 2009, he received the coveted Olympus Innovation Award
for teaching pedagogy in technology and innovation management. In addition to teaching the traditional
graduate and undergraduate curricular offerings, Dr. Camp is the architect and developer of the new and
growing Undergraduate Interdisciplinary Minor in Entrepreneurship and the Technology Entrepreneurship
and Commercialization (TEC) Academy at The Ohio State University. TEC is a proposed interdisciplinary,
graduate-level specialization training in the strategies and techniques for evaluating the commercial
potential of new technologies. TEC teams work with local technology or entrepreneurial experts to
develop commercialization strategies for live technologies provided by technology hosts (e.g., Battelle
Memorial Institute, OhioHealth, Ohio University, The Ohio State University and The Research Institute
at Nationwide Children’s Hospital).
Dr. Camp’s research interests focus on the creation and performance of new ventures and the
regional economic impact of innovation and entrepreneurship. He has published articles in leading
journals including Strategic Management Journal, Academy of Management Executive, and Entrepreneurship
Theory & Practice. Throughout his research career, including five years as vice president of research
for the Ewing Marion Kauffman Foundation, the world’s leading foundation in the advancement of
entrepreneurship, Professor Camp has directed or led several national and global programmatic
research initiatives. He teaches graduate and undergraduate courses in the entrepreneurship program.
His consulting work focuses on technology commercialization, new venture creation, the strategic
and financial performance of high-growth ventures, and the regional economic impact of the
innovation-entrepreneurship nexus. Dr. Camp holds dual degrees from two institutions, including a
PhD in business strategy and a master’s degree in organization theory from The Ohio State University,
and an MBA and BS in business administration from West Virginia University.
Steven G. Gabbe, MD
Dr. Steven Gabbe is the Senior Vice President for Health Sciences for
The Ohio State University and Chief Executive Officer of The Ohio State
University Medical Center. Since returning to Ohio State in this new role in 2008, Dr. Gabbe has led the Medical Center to its first ranking on the U.S. News &
World Report “Best Hospitals” Honor Roll of the nation’s top 21 hospitals; to
recertification as a Magnet Hospital for nursing excellence; to honors as a Best Place to Work in central Ohio for the third consecutive year; to growth in
biomedical research funding to more than $205 million per year; and to University Board of Trustees
approval of ProjectONE, the largest construction project in University history. The $1-billion ProjectONE
will be completed in 2014 and include a new cancer hospital, critical care tower, outpatient center,
research laboratories and classrooms – all designed to advance the Medical Center’s mission to
improve people’s lives through innovation in patient care, education and research.
A native of New Jersey, Dr. Gabbe earned his undergraduate degree magna cum laude from Princeton
University and his medical degree with Alpha Omega Alpha honors from Cornell University Medical
College. He was a medical intern at New York Hospital, a research fellow in reproductive medicine at
Boston Hospital for Women and a research fellow in biological chemistry at Harvard Medical School
before completing his residency in obstetrics and gynecology at Boston Hospital for Women and a
clinical fellowship in obstetrics and gynecology at Harvard Medical School.
Dr. Gabbe served on the obstetrics and gynecology faculties of the University of Southern California,
University of Colorado and University of Pennsylvania before joining The Ohio State University College
of Medicine in 1987 as Professor and Chair of Obstetrics and Gynecology. He was named Chair of
Obstetrics and Gynecology at the University of Washington Medical Center in 1996 and Dean of the
Vanderbilt University School of Medicine in 2001. During Dr. Gabbe’s tenure at Vanderbilt, National
Institutes of Health research funding increased by 77 percent and the number of faculty grew by 66
percent, to more than 1,800. He was recruited to Ohio State as Senior Vice President for Health
Sciences and CEO of its Medical Center in 2008.
Dr. Gabbe is one of the world’s leading experts on the complications of diabetes and pregnancy.
He is the author of more than 170 peer-reviewed papers and senior editor of the leading textbook in his
field, Obstetrics: Normal and Problem Pregnancies. Dr. Gabbe has held leadership positions with the
Association of American Medical Colleges (AAMC) and National Institutes of Health (NIH). He also
served as Co-Chair of the Liaison Committee for Medical Education, the accreditation body for North
American medical schools. Dr. Gabbe is a member of the Institute of Medicine and, in 2009 was
appointed chair of the AAMC MR5 MCAT Review Committee.
Dr. Gabbe and his wife, Dr. Patricia Temple Gabbe, have four children: Adam, Erica, Amanda, and
Daniel; and two grandchildren: Alexander and Marin.
Rebecca D. Jackson, MD
Dr. Jackson is Director of The Ohio State University Center for Clinical and Translational Science, the academic home of the National Institutes of
Health (NIH) Clinical and Translational Science Award (CTSA). She participated in formalized programs of clinical and translational research training as a
junior faculty member, first through the National Center for Research Resources (NCRR)-sponsored Clinical Associate Physician Award and later through a
Physician Scientist Award to develop expertise in molecular biology and basic science discovery.
She has been a faculty member at The Ohio State University College of Medicine since 1983, and in
August 2006, having accepted the position as PI and Director of the Center for Clinical and Translational
Science (CCTS), she was promoted to Associate Dean for Clinical Research in Ohio State’s
College of Medicine, reporting directly to the Senior Vice President for Health Sciences. Dr. Jackson is a
well-recognized clinical and translational investigator in metabolic bone disease and women’s health.
She has had continuous funding for the past 20 years and has been PI of two large longitudinal studies:
the NHLBI-sponsored Women’s Health Initiative and the NIAMS-sponsored Osteoarthritis Initiative.
Currently, Dr. Jackson is PI on NIH U01(1) and NIH N01(1) and co-investigator on NIH R01(3) and in
January 2007 received funding as PI of a genome-wide association study of the genetic determinants of
hip fracture. She was the founding director of Ohio State’s CCC Clinical Trials Office (CTO). Under her
leadership at CCC-CTO, the clinical and translational research effort at The Ohio State University
Comprehensive Cancer Center –Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
was transformed to a novel, integrated and robust shared service. The fact that this fundamental change
in the conduct of clinical research at Ohio State’s Comprehensive Cancer Center-James Cancer Hospital
(OSUCCC-James) took place over less than 14 months and culminated in funding by the National Cancer
Institute demonstrates Dr. Jackson’s energy and commitment to working with individuals to create
consensus and develop systems that are responsive to investigators.
As the PI of the CTSA and Director of the CCTS, Ohio State has invested Dr. Jackson with the
authority to lead the University’s development of clinical and translation research. She has ultimate
responsibility for programmatic functions, operations and strategic planning for Ohio State’s CCTS.
Dr. Jackson is the primary contact to facilitate and maximize collaboration and interaction between the
CCTS, the NIH (NCRR) and national CTSA consortium, as well as both internal and external groups and
individuals. She represents the CCTS and its mission to support clinical and translation science at the
University’s highest leadership levels; chairs the CCTS Management Committee to integrate the needs
of the CCTS with The Ohio State University Medical Center and OSUCCC-James; and chairs the CCTS
Executive Committee. Dr. Jackson is responsible for the management of CCTS functions and has direct
responsibility for performance of co-PIs and key program leaders with the advice of the Executive
Committee. She works with the CCTS Administrative Director to maximize the value of resources and
programs across the Ohio State member Colleges by identifying priorities and new directions. Dr. Jackson
oversees the formal ongoing evaluation and process improvement program and negotiates priorities
among key programs. She is responsible for ensuring the adoption of best practices in all CCTS research
support programs.
Michael Leiblein, PhD
Michael Leiblein, PhD, is an Associate Professor in the Strategic Management group of The Ohio State University Fisher College of Business. Professor Leiblein’s research examines the relationship between firm organization and performance
in technology-intensive industries. His recent work examines relationships
between aspects of technical problems (e.g., problem complexity and structure, exchange specificity and uncertainty), organization (e.g., outsourcing and various
alliance structures) and performance (e.g., static and dynamic changes in technical and financial
performance). His research has received a number of academic awards and been disseminated into
practice through outlets such as the Financial Times of London. Professor Leiblein has led courses and
seminars on business, corporate, and technology strategy in a variety of undergraduate, master’s,
doctoral, and executive programs and has consulted on issues relating to business, corporate, and
technology strategy in the U.S. and Europe for a wide range of firms and industry groups. In his free time,
he enjoys hiking and sightseeing throughout the American Southwest.
Earl LeVere
Earl LeVere is a Partner in Schottenstein Zox & Dunn ’s Intellectual Property
and Technology Practice Area and its Commercial Litigation Practice Group, where he focuses on intellectual property and information technology issues related to patent, copyright, trademark, life sciences, computer, internet, ecommerce
disputes and entertainment law.
Throughout his practice, Mr. LeVere has represented clients in intellectual
property litigation matters across the country; helped clients establish internal
procedures to protect proprietaryinformation; drafted intellectual property license and assignment
agreements and agreements for the joint development and use of intellectual property.
Clay Marsh, MD
Dr. Marsh is Senior Associate Vice President for Health Sciences
Research, Vice Dean for Research for The Ohio State University College of
Medicine, Executive Director of Ohio State’s Center for Personalized Health, and the Director of the Center for Critical Care and Respiratory Medicine. He is also Professor of Internal Medicine and former director of the Division of Pulmonary,
Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine.
Dr. Marsh received his undergraduate (Biology) and medical degrees at West Virginia University
and did his Internal Medicine residency and Pulmonary and Critical Care fellowship at The Ohio State
University in Internal Medicine. He began his academic career in the Division of Pulmonary Medicine
as a clinical instructor in 1993 and in 2003 became the director of the division. Dr. Marsh then ascended
to directorship of the Center for Critical Care and Respiratory Medicine, one of Ohio State’s Medical
Center signature programs that oversees institutional clinical, educational and research programming
in critical care, respiratory disease, trauma, wound, burn, sleep and allergy-based care. In 2009, he took
his present position as Vice Dean for Research in the College of Medicine and as Senior Associate Vice
President for Research in the Office of Health Sciences.
Dr. Marsh is an NIH-funded investigator and his laboratory focuses on translational research in the
area of macrophage biology, with an emphasis on pulmonary fibrosis and tissue microenvironment/
angiogenesis and applied genomics related to these areas. Also interested in understanding the
molecular mechanisms underlying human health and wellness, Dr. Marsh leads the efforts in
Personalized Health Care at The Ohio State University, where he and the University’s senior leadership
are directing the effort in transforming healthcare delivery by creating pilot programs in wellness and
chronic disease, testing solutions that produce lower cost and higher quality outcomes. Under his
direction, Ohio State is a partner in the Coriell Institute’s Personalized Medicine Collaborative.
Dr. Marsh is leading Ohio State’s efforts in partnering with the Institute for Systems Biology to create
the P4 Medicine Institute.
Listed in America’s Best Doctors©, he has a rich history of mentoring MD, MD/PhD and PhD
students, post-doctoral researchers and junior faculty.
Dr. Marsh is the former director of the scientific board and the immediate past chair of the Board of
Directors of the Stanley Sarnoff Foundation for Cardiovascular Medicine, and is on the National Advisory
Board for the Pulmonary Bioinitiative for Lung Health and Disease with Battelle Memorial Institute and
the Institute for Systems Biology.
Jane New
Jane New joined The Ohio State University Office for Technology Licensing in 2001 and is primarily responsible for the licensing and commercialization of the University’s life sciences portfolio. In her current role as associate director, she
continues to work with Ohio State’s Colleges of Medicine, Pharmacy, Biological
Sciences, Veterinary Medicine and Food, Agriculture & Environmental Science. Prior to joining Ohio State, New was President of the Kansas Innovation
Corporation, where she focused on technology transfer and technology-based new business
development in Northeast Kansas and managed a pre-seed fund and its portfolio of investments.
She has also consulted for the National Institutes of Standards and Technology in its Advance Technology
Program. New holds both an MBA and a Master’s Degree in Accounting and Information Systems from
the University of Kansas.
Sampath Parthasarathy, PhD, MBA, FAHA
Sampath Parthasarathy, PhD, MBA, FAHA is a biomedical scientist with a
research focus on lipids, lipoproteins, oxidative stress and the biology of
endothelial cells and macrophages and an emphasis on chronic diseases, including atherosclerosis, diabetes and heart failure. His primary appointment is as holder
of the Klassen Chair and Professor of Surgery, with secondary appointments as professor of Internal Medicine and as Professor of Human Nutrition. He directs research in the division of cardiothoracic surgery.
Dr. Parthasarathy obtained his PhD in Biochemistry from the Indian Institute of Science and served
as a postdoctoral fellow in several institutions. He was a faculty member at the University of California,
San Diego, Emory University, and the Louisiana State University Medical School before joining The Ohio
State University Medical Center.
Dr. Parthasarathy, who has been credited with the co-discovery of oxidized low density lipoprotein, has
published over 225 full-length research articles and authored a book, Modified Lipoproteins in the Pathogenesis of Atherosclerosis. He serves on the editorial boards of several journals and on numerous national
and international committees. Dr. Parthasarathy organized several national and international conferences
and has won numerous awards, including a Special Recognition Award from the American Heart Association, the Ranbaxy award, and Van Deenen Memorial Lecture. In addition, he has trained more than one
hundred graduate students and postdoctoral fellows and was recently named as the Mentor of the Year
by The Ohio State University Davis Heart and Lung Research Institute. Finally, Dr. Parthasarathy has been
continuously funded by the National Institutes of Health for more than 25 years.
One of the founders of InVasc Therapeutics, Inc., an Atlanta/Columbus based-pharmaceutical
company interested in cardiovascular drug development, he is internationally recognized for his work
in the area of atherosclerosis. Dr. Parthasarathy has been extensively involved in drug discovery and
served as a consultant for numerous major pharmaceutical companies, including Bristol Myers Squibb,
Johnson & Johnson, Atherogenics, and Vyrex Pharmaceuticals.
Dr. Parthasarathy synthesized and patented water-soluble probucol at the University of California
in San Diego. It was this compound that later formed the basis for AGI-1067, the lead product for
Atherogenics which raised nearly $700 million to advance it.
Dr. Parthasarathy holds several patent rights and has designed many of the key agents under
investigation at InVasc Therapeutics.
Vincent J. Pompili, MD, FACC
Vincent J. Pompili, MD, FACC is Director of Interventional Cardiovascular
Medicine and Director of Cell-Based Therapies at The Ohio State University
Medical Center in Columbus, Ohio. He is also a Professor of Internal Medicine
at The Ohio State University College of Medicine.
After graduating from The Case Western Reserve University School of
Medicine, Dr. Pompili completed his residency at Johns Hopkins University,
followed by a fellowship in Cardiology at The University of Michigan and a fellowship in Interventional
Cardiology at The Mayo Clinic.
Dr. Pompili’s primary clinical focus is interventional cardiology and acute coronary syndromes,
and his research interest is cardiovascular regenerative medicine. He served as the national principal
investigator on the third FDA approved clinical trial in stem cell therapeutics in the United States and
holds expertise in the pre-clinical and clinical trial design of these types of studies. He also has been
a principal investigator in numerous National Institutes of Health (NIH) sponsored clinical trials.
Dr. Pompili has published numerous journal articles in such publications as Circulation, American
Journal of Medicine, Cell Transplantation, Angiology, Journal of the American College of Cardiology and
Cardiovascular Research.
In addition to seeing patients at The Ohio State University Richard M. Ross Heart Hospital, Dr. Pompili
also supports Ohio State’s University Hospital East Heart Program
Christine A. Poon
Christine A. Poon was appointed Dean and John W. Berry, Sr. Chair in
Business at The Max M. Fisher College of Business at The Ohio State University
in April 2009. Poon comes to Fisher after a 30-year career in the healthcare
industry, most recently as vice chairman and worldwide chairman of
Pharmaceuticals at Johnson & Johnson. She served as a member of the company’s Board of Directors and Executive Committee and was responsible for managing the
pharmaceutical businesses of the company. Her areas of expertise include domestic and international
business operations and sales and marketing.
Poon began her career at Johnson & Johnson in 2000 as company group chairman of Pharmaceuticals and was appointed worldwide chairman of Pharmaceuticals in 2001. She was appointed worldwide
chairman of Medicines & Nutritionals in 2003 and was named a vice chairman of the Board of Directors
in 2005. In 2007, Poon assumed responsibility for the Johnson & Johnson Development Corporation,
the Corporate Office of Science and Technology, the Corporate Office of Information Management,
Worldwide Procurement and Worldwide Operations.
Prior to joining Johnson & Johnson, Poon spent 15 years at Bristol-Myers Squibb, where her most
recent position was president of International Medicines. Her career at Bristol-Myers Squibb comprised
marketing and strategic planning positions, including stints as president of Medical Devices and senior
vice president for Canada and Latin America Pharmaceutical Operations.
Poon is on the Board of Directors of Prudential Financial, Inc., in Newark, N.J., and the Supervisory
Board of Royal Philips Electronics in Amsterdam. She was recently named to Boston University’s Board
of Trustees. In 2004, she was named Woman of the Year by the Healthcare Businesswomen’s
Association and in 2005 named Business Leader of the Future by CNBC/Wall Street Journa.
Poon earned a BA in Biology from Northwestern University, an MA in Biology/Biochemistry
from St. Louis University and an MBA in Finance from Boston University.
Susan Rector
Susan Rector, Partner, leads Schottenstein Zox & Dunn’s Intellectual Property Practice Group, which oversees the professional quality of service delivered to
clients in intellectual property law. She has advised publicly and privately held
companies in all aspects of intellectual property ownership and has assisted
start-up and established businesses in conducting business online or
commercializing technology.
Rector has extensive experience with software acquisition and licensing, technology-based
companies and the legal issues encountered in conducting business online. She has prosecuted more
than 450 applications with the U.S. Patent and Trademark Office and numerous applications with the U.S.
Copyright Office. Rector also has experience in a wide variety of business transactions, including business
formation, restructurings and mergers and acquisitions. She has advised institutional investors in making
investments in venture capital funds or other equity investments and has assisted companies in raising
debt and equity through the private sale of securities. Rector also provides ongoing advice and counsel
to family- and privately-held businesses. Complementing her practice, she serves as partner in charge of
marketing and business development. In this role, she oversees the firm’s marketing strategies and brand
development to successfully position Schottenstein Zox & Dunn within the legal industry. Rector also
serves as the editor of Currents, the firm’s newsletter, which features issues and trends in intellectual
property and e-commerce law.
Anthony Rucci
Tony Rucci joined the faculty at the Fisher College of Business at Ohio State University in 2006 following a 25 year career as an executive officer with three
Fortune 100 companies: Baxter International, where he was Senior Vice President of Corporate Strategy and Business Development; Sears Roebuck and Co., where
he was Executive Vice President and Chief Administrative Officer; and Cardinal Health, where he was President of Strategic Corporate Resources and Chief
Administrative Officer. He has held a broad range of senior officer responsibilities, including extensive
board of directors and governance experience, merger and acquisition responsibilities, large scale
organizational transformation efforts, as well as international responsibilities. His roles have included
global responsibility for corporate strategy and business development, legal, human resources, investor
relations, information technology, quality and regulatory affairs, media relations and communications,
government affairs, corporate branding, procurement and sourcing, ethics, security, real estate, aviation
. . . . continues on next page
. . . . continued from previous page
and crisis management. He has also been Chairman of the Board of Sears Mexico, and held a joint role as
CEO of the Ohio State University Physicians, Inc. and Senior Associate Vice President for Health Sciences
at the Ohio State University Medical Center.
Academically, Rucci has been Dean of the College of Business at the University of Illinois, Chicago
and a tenured professor. He has published over twenty five articles and book chapters, including the
Harvard Business Review and Fortune magazine. He has been on the editorial board of several
professional journals, as well as an ad hoc reviewer for book publishers, including Harvard Business
School Press. He has taught at several universities, including Ohio State University, Bowling Green State
University, the University of Illinois, Chicago, and the University of Texas, Dallas. He is a frequently sought
speaker, and has delivered over 125 invited speeches and keynote addresses over the past ten years at
major conferences and events. Rucci holds bachelors, masters and PhD degrees in Industrial and
Organizational Psychology from Bowling Green State University. His current teaching, publication and
consulting activities focus on the areas of strategy development and execution, leadership effectiveness,
team effectiveness, and the role of intangibles in the value creation chain. Most recently, he has received
the 2010 Pacesetter Award from the Fisher College for Best Graduate Faculty, the 2008 Distinguished
Career Executive Award by the Academy of Management, as well as the Outstanding Professor Award
from the 2009 MBA class and the 2008 Executive MBA class at Ohio State University. (8.09)
Chandan Sen, PhD
Chandan Sen, PhD, is a tenured Professor of Surgery and Associate Dean for Research in The Ohio State University College of Medicine. He is also Executive Director of the Ohio State University Comprehensive Wound Center. Dr. Sen directs the Medical Center’s Technology Commercialization and Industry Partnership
program. He also serves on the National Institutes of Health (NIH) panel on
public-private partnerships. Dr. Sen has been appointed Champion of Change (CoC) for Ohio State on the NIH national CoC program. He directs two programs
in The Ohio State University’s CTSA (NIH Clinical and Translational Science Award) program - the Center
for Clinical and Translational Science (CCTS: the Novel Technologies/Methodologies program and the
Pilot Studies program). Dr. Sen has been appointed by College Dean Wiley Souba, MD, to develop
strategic partnerships between the College of Medicine and The Ohio State University Fisher College
of Business. For the last 10 years he has been editor-in-chief of the #1 rated journal in oxygen & redox
biology, Antioxidants & Redox Signaling, which has an impact factor 6.19. Dr. Sen is also an associate
editor of the prestigious American Physiological Society journal, Physiology Genomics. He is editor-inchief of the Wound Healing Society’s yearbook Advances in Wound Care. Dr. Sen has published more
than 250 publications and is cited more than 700 times yearly in the literature of his field. He is a
permanent member of the NIH Surgery, Anesthesia and Trauma study section.
Orlando “Lon” Simonetti, PhD
After receiving his BS in zoology with a minor in electrical engineering and
MS degree in biomedical engineering from The Ohio State University, Dr. Simonetti began his career in MRI research in 1989 as a graduate student in biomedical engineering at Case Western Reserve University, where he earned his doctorate. In 1992, he joined the Siemens MRI Research and Development group, and by 1997 was promoted to Director of Cardiovascular MR R&D at Siemens. During his
13-year career at Siemens, Dr. Simonetti patented nine cardiovascular MRI techniques and was
responsible for developing many of the methods that have become mainstays of cardiovascular MRI.
He has more than 75 peer-reviewed articles, and his article on delayed enhancement imaging is the
most widely cited article of the past 25 years in the journal Radiology.
In 2005, Dr. Simonetti accepted a position at The Ohio State University as director of cardiovascular
MRI and CT research at the OSU Ross Heart Hospital. He currently serves on the board of trustees of
the Society for Cardiovascular Magnetic Resonance and the editorial board for the Journal of Cardiovascular Magnetic Resonance. This year, Dr. Simonetti was named a Fellow of the International Society for
Magnetic Resonance in Medicine, where he chairs the Student Stipend Committee and serves on several
other committees.
In 2008, together with two other Ohio State University faculty members and one Ohio State
graduate student, he founded EXCMR, Ltd to commercialize technology that enables a new method of
cardiovascular stress testing. The company took second place in the 2008 Fisher Student Business
Plan Competition in Ohio State’s Fisher College of Business, and was named Central Ohio Startup of
the Year in 2009. EXCMR has received grant funding from TechColumbus, The Global Cardiovascular
Innovations Center and the National Institutes of Health. The company has used this funding for
market research, to perform clinical feasibility studies at Ohio State and to design a production
prototype. EXCMR hopes to enter the market with their device next year.
Chip Souba, MD, ScD, MBA
Wiley W. “Chip” Souba (pronounced SHOW-buh) serves as Dean of the
College of Medicine and Vice President and Executive Dean for Health Sciences
at The Ohio State University. He holds a faculty appointment as professor in the Department of Surgery and in Physiology and Cell Biology.
Before coming to Ohio State in 2006, Dr. Souba served as Chairman of
the Department of Surgery at Penn State College of Medicine, Surgeon-in-Chief
at Penn State’s Hershey Medical Center and Director of the Penn State Hershey Center for Leadership
Development. Prior to assuming his position at Penn State, he served as Chief of Surgical Oncology at the
Massachusetts General Hospital and Professor of Surgery at Harvard Medical School from 1993 to 1999.
He began his career as a faculty member at the University of Florida in 1987.
Dr. Souba is an Alpha Omega Alpha (AOA) graduate of the University of Texas Medical School
in Houston, where he subsequently did his general surgery training. During his surgical residency,
Dr. Souba completed a fellowship in surgical research at the Brigham and Women’s Hospital and
earned a Doctorate in Science in Nutritional Biochemistry at the Harvard School of Public Health.
. . . . continues on next page
. . . . continued from previous page
In addition, he did a senior fellowship in Surgical Oncology at the MD Anderson Hospital and Tumor
Institute in Houston, Texas.
Dr. Souba has been ranked as one of The Best Doctors in America by his peers and has been
recognized for his clinical expertise by Boston Magazine. He was funded by the NIH for 20 years to
study the regulation of the altered amino acid metabolism that is characteristic of catabolic diseases
and has published nearly 300 articles and 75 book chapters in this field. Dr. Souba has served as
Editor of the Journal of Surgical Research since 1997 and was Editorial Chair of ACS Surgery from
2004-2009.
Dr. Souba has long-standing interest in leadership development and has published more than
30 peer reviewed articles on topics such as adaptive challenges, change in academic medicine,
professionalism, language and leadership, and leading oneself. He lectures globally on these topics.
Dr. Souba and his wife have two children.
Karen Hopper Wruck, PHD
Karen Wruck, PhD, is Associate Dean for Graduate Programs, Dean’s
Distinguished Professor and Professor of Finance at The Ohio State University Fisher College of Business. She conducts research and teaches in the fields of financial and organizational economics, specializing in corporate finance,
restructuring, financial distress, corporate governance and management
compensation. Dr. Wruck has published numerous articles in leading academic
journals and developed highly successful courses for delivery to MBAs and executives. In addition, her
work and opinions have been highlighted in business periodicals. Dr. Wruck is associate editor of the
Journal of Financial Economics, Journal of Corporate Finance, Journal of Financial Research and European
Financial Management and serves as ad hoc referee for many other academic journals. She has been
selected as the outstanding faculty member by students in the core of the full-time MBA program and
the executive MBA program at Ohio State, and has received a faculty-selected award for exceptional
contributions toward graduate student intellectual and cultural growth at the University. Dr. Wruck
serves as an academic director of the Financial Management Association and the Turnaround
Management Association. A consultant to major corporations, she has worked on a number of high
profile corporate litigation projects as an expert witness. Dr. Wruck holds an AB from Davidson College
in Economics, and both an MS in Applied Economics and a PhD in Finance and Accounting from the
University of Rochester. Prior to her appointment at Ohio State’s Fisher College of Business, Dr. Wruck
was an associate professor at the Harvard Business School.
The project described was supported by Award Number UL1RR025755 from the National Center For Research Resources.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center
For Research Resources or the National Institutes of Health.